Actively Recruiting
Study of Platelet Population Changes Under Circulatory Support With ECMO
Led by University Hospital, Strasbourg, France · Updated on 2026-01-12
75
Participants Needed
1
Research Sites
104 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Advances in flow cytometry techniques have led to a better understanding of platelet phenotypes and have revealed the existence of four major platelet populations with distinct functional properties (native, proaggregating, procoagulating, or apoptotic). These phenotypes have a significant impact on the hemostatic capacity of blood platelets, and a proportional change in these populations during ECMO treatment could, at least in part, contribute to the observed complications.
CONDITIONS
Official Title
Study of Platelet Population Changes Under Circulatory Support With ECMO
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Adult patient (≥18 years) treated in one of the intensive care units of the Anesthesia and Intensive Care Department at Strasbourg University Hospital.
- Implanted with veno-arterial or veno-venous ECMO within the previous 24 hours.
You will not qualify if you...
- Subject who has expressed their opposition to participating in the study.
- Subject under legal protection.
- Subject under guardianship or curatorship.
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Service d'anesthésie-réanimation - CHU de Strasbourg - France
Strasbourg, France, 67091
Actively Recruiting
Research Team
C
Charles TACQUARD, MD, PhD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here